Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Endovascular Institute is a Florida-based outpatient cardiovascular and endovascular care provider associated with Ansaarie Cardiac and Endovascular. The organization focuses on interventional cardiology and endovascular interventions for heart and vascular disease patients, particularly in the St. Augustine and East Palatka area. Its public-facing materials emphasize minimally invasive arterial and peripheral vascular procedures and highlight a proprietary technique called MáLEI intended to shorten recovery time for selected peripheral artery disease procedures. The business appears to operate as a clinical healthcare services company rather than a drug-development biotech or pharmaceutical company. There is no evidence of a therapeutic drug pipeline, regulated biologics platform, or conventional pharma partnering activity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Endovascular Institute.